Colecistoquinina (Galician Wikipedia)

Analysis of information sources in references of the Wikipedia article "Colecistoquinina" in Galician language version.

refsWebsite

Global rank Galician rank

11nih.gov

4^th place

6^th place

8doi.org

2^nd place

7^th place

3worldcat.org

5^th place

11^th place

2web.archive.org

1^st place

2physiology.org

5,293^rd place

1,694^th place

1anesthesia-analgesia.org

low place

1archive.org

6^th place

8^th place

1gastrojournal.org

low place

1u-szeged.hu

low place

anesthesia-analgesia.org

Kissin I, Bright CA, Bradley EL (2000). "Acute tolerance to continuously infused alfentanil: the role of cholecystokinin and N-methyl-D-aspartate-nitric oxide systems". Anesth. Analg. 91 (1): 110–6. PMID 10866896. doi:10.1097/00000539-200007000-00021.

archive.org

Greenough A, Cole G, Lewis J, Lockton A, Blundell J (1998). "Untangling the effects of hunger, anxiety, and nausea on energy intake during intravenous cholecystokinin octapeptide (CCK-8) infusion". Physiol. Behav. 65 (2): 303–10. PMID 9855480. doi:10.1016/S0031-9384(98)00169-3.

doi.org

dx.doi.org

Kissin I, Bright CA, Bradley EL (2000). "Acute tolerance to continuously infused alfentanil: the role of cholecystokinin and N-methyl-D-aspartate-nitric oxide systems". Anesth. Analg. 91 (1): 110–6. PMID 10866896. doi:10.1097/00000539-200007000-00021.
Fukazawa Y, Maeda T, Kiguchi N, Tohya K, Kimura M, Kishioka S (2007). "Activation of spinal cholecystokinin and neurokinin-1 receptors is associated with the attenuation of intrathecal morphine analgesia following electroacupuncture stimulation in rats". J. Pharmacol. Sci. 104 (2): 159–66. PMID 17558184. doi:10.1254/jphs.FP0070475.
Greenough A, Cole G, Lewis J, Lockton A, Blundell J (1998). "Untangling the effects of hunger, anxiety, and nausea on energy intake during intravenous cholecystokinin octapeptide (CCK-8) infusion". Physiol. Behav. 65 (2): 303–10. PMID 9855480. doi:10.1016/S0031-9384(98)00169-3.
Fink H, Rex A, Voits M, Voigt JP (1998). "Major biological actions of CCK--a critical evaluation of research findings". Exp Brain Res 123 (1–2): 77–83. PMID 9835394. doi:10.1007/s002210050546.
Harikumar, Kaleeckal G; Clain Jeremy, Pinon Delia I, Dong Maoqing, Miller Laurence J (2005). "Distinct molecular mechanisms for agonist peptide binding to types A and B cholecystokinin receptors demonstrated using fluorescence spectroscopy". J. Biol. Chem. (United States) 280 (2): 1044–50. ISSN 0021-9258. PMID 15520004. doi:10.1074/jbc.M409480200.
Galés, Céline; Poirot Marc, Taillefer Julien, Maigret Bernard, Martinez Jean, Moroder Luis, Escrieut Chantal, Pradayrol Lucien, Fourmy Daniel, Silvente-Poirot Sandrine (2003). "Identification of tyrosine 189 and asparagine 358 of the cholecystokinin 2 receptor in direct interaction with the crucial C-terminal amide of cholecystokinin by molecular modeling, site-directed mutagenesis, and structure/affinity studies". Mol. Pharmacol. (United States) 63 (5): 973–82. ISSN 0026-895X. PMID 12695525. doi:10.1124/mol.63.5.973.
Gurda, Grzegorz T.; Guo LiLi, Lee Sae-Hong, Molkentin Jeffery D, Williams John A (2008). "Cholecystokinin Activates Pancreatic Calcineurin-NFAT Signaling In Vitro and In Vivo". Mol. Biol. Cell. (United States) 19 (198–206): 198–205. PMC 2174201. PMID 17978097. doi:10.1091/mbc.E07-05-0430.
Tsujino N, Yamanaka A, Ichiki K, Muraki Y, Kilduff TS, Yagami K-I, Takahashi S, Goto K, Sakurai T (2005). "Cholecystokinin Activates Orexin/Hypocretin Neurons through the Cholecystokinin A Receptor". The Journal of Neuroscience 25 (32): 7459–7469. PMID 16093397. doi:10.1523/JNEUROSCI.1193-05.2005.

gastrojournal.org

Yukari Date et al. The role of the gastric afferent vagal nerve in ghrelin-induced feeding and growth hormone secretion in rats. Gastroenterology. Volume 123, Issue 4 , Pages 1120-1128, October 2002. [2]

nih.gov

ncbi.nlm.nih.gov

Kissin I, Bright CA, Bradley EL (2000). "Acute tolerance to continuously infused alfentanil: the role of cholecystokinin and N-methyl-D-aspartate-nitric oxide systems". Anesth. Analg. 91 (1): 110–6. PMID 10866896. doi:10.1097/00000539-200007000-00021.
Fukazawa Y, Maeda T, Kiguchi N, Tohya K, Kimura M, Kishioka S (2007). "Activation of spinal cholecystokinin and neurokinin-1 receptors is associated with the attenuation of intrathecal morphine analgesia following electroacupuncture stimulation in rats". J. Pharmacol. Sci. 104 (2): 159–66. PMID 17558184. doi:10.1254/jphs.FP0070475.
Greenough A, Cole G, Lewis J, Lockton A, Blundell J (1998). "Untangling the effects of hunger, anxiety, and nausea on energy intake during intravenous cholecystokinin octapeptide (CCK-8) infusion". Physiol. Behav. 65 (2): 303–10. PMID 9855480. doi:10.1016/S0031-9384(98)00169-3.
Shillabeer G, Davison JS (1987). "Proglumide, a cholecystokinin antagonist, increases gastric emptying in rats". Am. J. Physiol. 252 (2 Pt 2): R353–60. PMID 3812772. Arquivado dende o orixinal o 24 de xullo de 2008. Consultado o 17 de xaneiro de 2012.
Bradwejn, J. (1993). "Neurobiological investigations into the role of cholecystokinin in panic disorder". Journal of Psychiatry and Neuroscience 18 (4): 178–88. PMC 1188527. PMID 8104032.
Fink H, Rex A, Voits M, Voigt JP (1998). "Major biological actions of CCK--a critical evaluation of research findings". Exp Brain Res 123 (1–2): 77–83. PMID 9835394. doi:10.1007/s002210050546.
Harikumar, Kaleeckal G; Clain Jeremy, Pinon Delia I, Dong Maoqing, Miller Laurence J (2005). "Distinct molecular mechanisms for agonist peptide binding to types A and B cholecystokinin receptors demonstrated using fluorescence spectroscopy". J. Biol. Chem. (United States) 280 (2): 1044–50. ISSN 0021-9258. PMID 15520004. doi:10.1074/jbc.M409480200.
Aloj, Luigi; Caracò Corradina, Panico Mariarosaria, Zannetti Antonella, Del Vecchio Silvana, Tesauro Diego, De Luca Stefania, Arra Claudio, Pedone Carlo, Morelli Giancarlo, Salvatore Marco (2004). "In vitro and in vivo evaluation of 111In-DTPAGlu-G-CCK8 for cholecystokinin-B receptor imaging". J. Nucl. Med. (United States) 45 (3): 485–94. ISSN 0161-5505. PMID 15001692.
Galés, Céline; Poirot Marc, Taillefer Julien, Maigret Bernard, Martinez Jean, Moroder Luis, Escrieut Chantal, Pradayrol Lucien, Fourmy Daniel, Silvente-Poirot Sandrine (2003). "Identification of tyrosine 189 and asparagine 358 of the cholecystokinin 2 receptor in direct interaction with the crucial C-terminal amide of cholecystokinin by molecular modeling, site-directed mutagenesis, and structure/affinity studies". Mol. Pharmacol. (United States) 63 (5): 973–82. ISSN 0026-895X. PMID 12695525. doi:10.1124/mol.63.5.973.
Gurda, Grzegorz T.; Guo LiLi, Lee Sae-Hong, Molkentin Jeffery D, Williams John A (2008). "Cholecystokinin Activates Pancreatic Calcineurin-NFAT Signaling In Vitro and In Vivo". Mol. Biol. Cell. (United States) 19 (198–206): 198–205. PMC 2174201. PMID 17978097. doi:10.1091/mbc.E07-05-0430.
Tsujino N, Yamanaka A, Ichiki K, Muraki Y, Kilduff TS, Yagami K-I, Takahashi S, Goto K, Sakurai T (2005). "Cholecystokinin Activates Orexin/Hypocretin Neurons through the Cholecystokinin A Receptor". The Journal of Neuroscience 25 (32): 7459–7469. PMID 16093397. doi:10.1523/JNEUROSCI.1193-05.2005.

physiology.org

ajpregu.physiology.org

Shillabeer G, Davison JS (1987). "Proglumide, a cholecystokinin antagonist, increases gastric emptying in rats". Am. J. Physiol. 252 (2 Pt 2): R353–60. PMID 3812772. Arquivado dende o orixinal o 24 de xullo de 2008. Consultado o 17 de xaneiro de 2012.

ajpgi.physiology.org

H. H. Holzer, C. M. Turkelson, T. E. Solomon, H. E. Raybould. Intestinal lipid inhibits gastric emptying via CCK and a vagal capsaicin-sensitive afferent pathway in rats. [1] Arquivado 04 de abril de 2016 en Wayback Machine.

u-szeged.hu

phd.szote.u-szeged.hu

Kapas, Levente (2010). Metabolic signals in sleep regulation: the role of cholecystokinin (Ph.D thesis). University of Szeged. http://www.phd.szote.u-szeged.hu/Elmeleti_DI/Disszertaciok/2010/de_Levente_Kapas.pdf.

web.archive.org

Shillabeer G, Davison JS (1987). "Proglumide, a cholecystokinin antagonist, increases gastric emptying in rats". Am. J. Physiol. 252 (2 Pt 2): R353–60. PMID 3812772. Arquivado dende o orixinal o 24 de xullo de 2008. Consultado o 17 de xaneiro de 2012.
H. H. Holzer, C. M. Turkelson, T. E. Solomon, H. E. Raybould. Intestinal lipid inhibits gastric emptying via CCK and a vagal capsaicin-sensitive afferent pathway in rats. [1] Arquivado 04 de abril de 2016 en Wayback Machine.

worldcat.org

Harikumar, Kaleeckal G; Clain Jeremy, Pinon Delia I, Dong Maoqing, Miller Laurence J (2005). "Distinct molecular mechanisms for agonist peptide binding to types A and B cholecystokinin receptors demonstrated using fluorescence spectroscopy". J. Biol. Chem. (United States) 280 (2): 1044–50. ISSN 0021-9258. PMID 15520004. doi:10.1074/jbc.M409480200.
Aloj, Luigi; Caracò Corradina, Panico Mariarosaria, Zannetti Antonella, Del Vecchio Silvana, Tesauro Diego, De Luca Stefania, Arra Claudio, Pedone Carlo, Morelli Giancarlo, Salvatore Marco (2004). "In vitro and in vivo evaluation of 111In-DTPAGlu-G-CCK8 for cholecystokinin-B receptor imaging". J. Nucl. Med. (United States) 45 (3): 485–94. ISSN 0161-5505. PMID 15001692.
Galés, Céline; Poirot Marc, Taillefer Julien, Maigret Bernard, Martinez Jean, Moroder Luis, Escrieut Chantal, Pradayrol Lucien, Fourmy Daniel, Silvente-Poirot Sandrine (2003). "Identification of tyrosine 189 and asparagine 358 of the cholecystokinin 2 receptor in direct interaction with the crucial C-terminal amide of cholecystokinin by molecular modeling, site-directed mutagenesis, and structure/affinity studies". Mol. Pharmacol. (United States) 63 (5): 973–82. ISSN 0026-895X. PMID 12695525. doi:10.1124/mol.63.5.973.